BMEA
BMEA
NASDAQ · Biotechnology

Biomea Fusion Inc

$1.50
-0.03 (-1.96%)
As of Apr 1, 3:15 PM ET ·
Financial Highlights (FY 2025)
Revenue
19.42M
Net Income
-2,266,322
Gross Margin
66.9%
Profit Margin
-11.7%
Rev Growth
+9.6%
D/E Ratio
1.27
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 66.9% 66.9% 66.9%
Operating Margin -13.8% -14.9% -15.5%
Profit Margin -11.7% -11.7% -10.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.42M 19.36M 17.02M
Gross Profit 13.00M 12.96M 11.39M
Operating Income -2,685,543 -2,883,777 -2,632,625
Net Income -2,266,322 -2,263,432 -1,770,857
Gross Margin 66.9% 66.9% 66.9%
Operating Margin -13.8% -14.9% -15.5%
Profit Margin -11.7% -11.7% -10.4%
Rev Growth +9.6% -8.7% +9.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 36.01M 43.94M 35.70M
Total Equity 28.41M 25.31M 25.85M
D/E Ratio 1.27 1.74 1.38
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -3,805,934 -3,485,255 -2,994,447
Free Cash Flow -1,809,844 -1,626,073 -1,604,802